Similar Items: Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective
- Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
- Total Laboratory Automation for Microbiology Activities: An HTA Analysis in an Italian Laboratory Setting
- Comparison of Measured 24-Hour Urinary Salt Excretion With Spot Urine and 24-Hour Dietary Recall Estimates Among Adolescents and Parents: Cross-Sectional Study
- Knowledge, attitude, and perception (KAP) of obesity among middle-aged overweight and obese adults in the Ho Municipality, Ghana: a cross-sectional study
- Predictive Value of Combined MEWS and NIPDS Scores for 24-Hour Clinical Deterioration in Emergency Observation Patients: A Prospective Cohort Study
- Mapping Digital Nudges and Recommender Systems for Obesity Prevention: Scoping Review